The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib/II study of the IDH1-mutant inhibitor ivosidenib with the BCL2 inhibitor venetoclax +/- azacitidine in IDH1-mutated hematologic malignancies.
 
Curtis Andrew Lachowiez
No Relationships to Disclose
 
Gautam Borthakur
No Relationships to Disclose
 
Sanam Loghavi
No Relationships to Disclose
 
Zhihong Zeng
No Relationships to Disclose
 
Tapan M. Kadia
No Relationships to Disclose
 
Lucia Masarova
No Relationships to Disclose
 
Koichi Takahashi
No Relationships to Disclose
 
George Dono Tippett
No Relationships to Disclose
 
Kiran Naqvi
No Relationships to Disclose
 
Prithviraj Bose
No Relationships to Disclose
 
Elias Jabbour
No Relationships to Disclose
 
Farhad Ravandi
No Relationships to Disclose
 
Naval Guastad Daver
No Relationships to Disclose
 
Guillermo Garcia-Manero
No Relationships to Disclose
 
Bilyana Stoilova
No Relationships to Disclose
 
Paresh Vyas
No Relationships to Disclose
 
Hagop M. Kantarjian
No Relationships to Disclose
 
Marina Konopleva
No Relationships to Disclose
 
Courtney Denton Dinardo
No Relationships to Disclose
 
Anna B. Halpern
No Relationships to Disclose